Nutex Health Data Breach: Edelson Lechtzin LLP Investigates Theft of Patient and Employee Data
PRNewswire (Tue, 1-Sep 9:58 PM ET)
Nutex Health Hospitals Earn Multiple Community Honors in Second Quarter 2026
PRNewswire (Mon, 31-Aug 5:30 AM ET)
Fifth Circuit Rejects "Ghost Rates" in Federal QPA Calculations Under the No Surprises Act
PRNewswire (Tue, 25-Aug 5:31 AM ET)
NUTEX HEALTH OPENS WEST LITTLE ROCK EMERGENCY HOSPITAL IN ARKANSAS
PRNewswire (Tue, 18-Aug 5:30 AM ET)
NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS
PRNewswire (Thu, 6-Aug 5:59 PM ET)
Nutex Health Schedules 2026 Second Quarter Financial Results Release and Conference Call
PRNewswire (Tue, 21-Jul 5:30 AM ET)
Kuehn Law Encourages Investors of Nutex Health, Inc. to Contact Law Firm
Globe Newswire (Tue, 9-Jun 5:13 PM ET)
Nutex Health's Revenue Surges 82% in 2025 as Stock Buyback Signals Confidence
Market Chameleon (Fri, 6-Mar 2:29 AM ET)
Market Chameleon (Mon, 22-Dec 5:33 AM ET)
Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.
Nutex Health trades on the NASDAQ stock market under the symbol NUTX.
As of September 4, 2026, NUTX stock price declined to $193.24 with 140,532 million shares trading.
NUTX has a beta of 1.52, meaning it tends to be more sensitive to market movements. NUTX has a correlation of 0.04 to the broad based SPY ETF.
NUTX has a market cap of $1.32 billion. This is considered a Small Cap stock.
Last quarter Nutex Health reported $211 million in Revenue and $9.38 earnings per share. This fell short of revenue expectation by $-5 million and exceeded earnings estimates by $4.35.
In the last 3 years, NUTX traded as high as $204.00 and as low as $4.16.
The top ETF exchange traded funds that NUTX belongs to (by Net Assets): AVUV, VTI, IWO, CALF, VXF.
NUTX has outperformed the market in the last year with a price return of +135.5% while the SPY ETF gained +20.8%. NUTX has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +45.5% and +2.5%, respectively, while the SPY returned +2.4% and +1.0%, respectively.
NUTX support price is $187.43 and resistance is $207.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NUTX shares will trade within this expected range on the day.
